Clinical trial
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
NCT07329686 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- October 1, 2025
- Completion date
- October 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corneal neovascularization, herpes simplex keratitis